M. Torchet

发表

Batch recall of French plasma‐derived products due to variant Creutzfeldt‐Jakob disease risk: the psychological impact on haemophilic patients, changes in their therapeutic demands and behaviour and ethical considerations

A. Aouba, A. Harroche, L. Frenzel, 2015, Haemophilia : the official journal of the World Federation of Hemophilia.

Evaluation of desmopressin for dental extractions in patients with hemostatic disorders.

M. Torchet, J. Goudemand, C. Gazengel, 1994, Oral surgery, oral medicine, and oral pathology.

Cytomegalovirus neuropathy in acquired immunodeficiency syndrome: A clinical and pathological study

C. Lacroix, C. Leport, M. Torchet, 1991, Annals of neurology.

Use of recombinant factor VIIa (NovoSeven) in patients with Glanzmann thrombasthenia.

D. S. Houston, M. Morfini, M. Torchet, 2001, Seminars in hematology.

Uncomplicated neurosurgical resection of a malignant glioneuronal tumour under haemostatic cover of rFVIIa in a severe haemophilia patient with a high‐titre inhibitor: a case report and literature review of rFVIIa use in major surgeries

E. Dezamis, A. Aouba, M. Torchet, 2010, Haemophilia : the official journal of the World Federation of Hemophilia.

European data of a clinical trial with a sucrose formulated recombinant factor VIII in previously treated haemophilia A patients

M. Torchet, C. Rothschild, H. Brackmann, 2002, Haemophilia : the official journal of the World Federation of Hemophilia.

Comparison of Anti‐Human and Anti‐Porcine Factor VIII Inhibitor Levels in 63 Patients with Severe Haemophilia A

M. Torchet, M. Bertrand, B. Boneu, 1993, Vox sanguinis.

Intracranial haemorrhages in French haemophilia patients (1991–2001): clinical presentation, management and prognosis factors for death

M. Torchet, H. Chambost, S. Claeyssens, 2005, Haemophilia : the official journal of the World Federation of Hemophilia.

Surgical synovectomy of the knee in young haemophiliacs: long-term results of a monocentric series of 23 patients

V. Rampal, C. Elie, M. Torchet, 2010, Journal of children's orthopaedics.

Open synovectomy of the ankle joint in young haemophiliacs: mid‐term to long‐ term results of a single‐centre series of 32 procedures

C. Elie, M. Torchet, C. Rothschild, 2015, Haemophilia : the official journal of the World Federation of Hemophilia.

Deaths associated with acquired haemophilia in France from 2000 to 2009: multiple cause analysis for best care strategies

M. Torchet, C. Rothschild, E. Jougla, 2012, Haemophilia : the official journal of the World Federation of Hemophilia.

Spontaneous obturator internus muscle haematoma: a new unpublished cause of ilioipelvic pain in haemophilia

A. Aouba, A. Harroche, L. Frenzel, 2013, Haemophilia : the official journal of the World Federation of Hemophilia.

Single‐dose (270 μg kg−1) recombinant activated factor VII for the treatment and prevention of bleeds in haemophilia A patients with inhibitors: experience from seven European haemophilia centres

M. Torchet, P. Laguna, S. Z. Šalek, 2009, Haemophilia : the official journal of the World Federation of Hemophilia.

Long‐term follow‐up of children with haemophilia – low incidence of infections with central venous access devices

J. Merckx, A. Aouba, A. Harroche, 2015, Haemophilia : the official journal of the World Federation of Hemophilia.

Use of HBV vaccine in hemophiliacs.

C. Bréchot, M. Torchet, F. Degos, 2009, Scandinavian journal of haematology. Supplementum.

Comparison of Anti-Human and Anti-Porcine Factor Vlll Inhibitor

M. Torchet, M. Bertrand, B. Boneu, 2009 .

Factor VIII inhibitors development following introduction of B‐domain‐deleted recombinant factor VIII in four hemophilia A previously treated patients

M. Torchet, C. Rothschild, N. Stieltjes, 2003, Journal of thrombosis and haemostasis : JTH.

Successful long‐term replacement therapy with FXIII concentrate (Fibrogammin® P) for severe congenital factor XIII deficiency: a prospective multicentre study

M. Torchet, S. Claeyssens, J. Borg, 2011, Journal of thrombosis and haemostasis : JTH.

Use of recombinant factor VIIa (NovoSeven) in patients with Glanzmann thrombasthenia.

M. Morfini, M. Torchet, C. Berger, 2001, Seminars in hematology.

Monoclonal Immunoglobulins in Haemophiliac Patients with HIV Infection

M. Torchet, C. Gazengel, A. Fischer, 1991, Thrombosis and Haemostasis.

Treatment of type III von Willebrand's disease with solvent/detergent-treated factor VIII concentrates.

M. Torchet, C. Rothschild, M. Dautzenberg, 1988, Nouvelle revue francaise d'hematologie.

Analysis of biological phenotypes from 42 patients with inherited factor VII deficiency: can biological tests predict the bleeding risk?

R. Favier, M. Torchet, M. Bertrand, 2004, Haematologica.

Screening for von Willebrand disease: contribution of an automated assay for von Willebrand factor activity

P. Landais, A. Aouba, M. Torchet, 2012, Haemophilia : the official journal of the World Federation of Hemophilia.